Three days driving the Appalachian Mountains seeking secret locations of historic or scenic value. Accumulate points for your team while you drive roads that were selected specifically for those that enjoy the act of driving. This is a Rally North America Scavenger hunt and we invite you to join Rally North America for the 4th annual Ohio Valley 700.

Group rates have been established for some of nicest properties this side of the Mississippi so you will also enjoy your downtime at properties such as the Wisp in gorgeous Deep Creek, Maryland or The Snowshoe Lodge in scenic Snowshoe. West Virginia. We welcome any inquires but please act quickly.

As of August 4th forty-six other teams of automotive enthusiasts have signed on leaving ONLY 14 spots remaining for this once a year event. Once we have a full roster of 60 teams additional teams will be placed on a waiting list where there are no guarantees of participation

Get in while you can, this will be the last Ohio Valley 700 hosted by Rally North America!

Cost $299.99 +$100 mandatory donation
Registration is Open:  60 Team MAX.

9-29-16  – Pre Rally – Auction – Drivers Meeting 6:00 PM
9-30-16  – Day 1 – Hershey PA – Deep Creek MD
10-01-16 – Day 2 – Deep Creek MD – Snow Shoe WV
10-02-16 – Day 3 – Snow Shoe WV – Athens Ohio – Finish line

Starting Grid is based upon total money raised.. you raise the most, you get Pole.

The Ohio Valley 700 was created to specifically raise awareness for Epilepsy. On every car you will notice a shield, wrapped in a banner with the name  Cody Converse embedded in it.  In 2013 a he died at the age of 17 from a condition known as SUDEP. (Sudden Death in Epilepsy).  He had been seizure free for almost a year, and was looking forward to getting his life started.  Since 2013 we have a collective group have raised over $80,000.00 for Epilepsy Awareness, and this year we are rallying for a CURE!  The Cure.  Citizens United in the Research for Epilepsy.

All corporate event sponsors are donated to CURE.

  • In case you ever wondered what a Rally North America event is all about, watch this.  Completely filmed and edited on the road by Team Jack, during the CJ Pony Parts Big Sky Rally 2016.
Take a look at what a typical Rally North America event is like!  This video was created and produced by Team Jack on the Big Sky Rally this past summer!

Rally North America ; Big Sky 2016 from dkfx on Vimeo.


CURE officeCitizens United for Research in Epilepsy (CURE), is the leading nongovernmental agency fully committed to funding research in epilepsy. The organization was founded by Susan Axelrod and a small group of parents of children with epilepsy who were frustrated with their inability to protect their children from seizures and the side effects of medications. Unwilling to sit back, they joined forces to spearhead the search for a cure.

Since its inception in 1998, CURE has been at the forefront of epilepsy research, raising more than $40 million to fund research and other initiatives that will lead the way to a cure for epilepsy. CURE funds grants for young and established investigators and has awarded more than 200 cutting-edge projects in 15 countries around the world to date.

In May 2014, CURE launched a new signature program, the Epilepsy Genetics Initiative (EGI). With an initial $1 million in funding, EGI will create a comprehensive, interactive database where patients can have their genetic data repeatedly analyzed in an effort to identify the cause of their epilepsy. These data will also be made available to epilepsy researchers in an effort to find new causes of epilepsy and use these findings to guide treatment. EGI brings patients, medical professionals, and researchers together in a mutually beneficial way to advance the genetics of epilepsy and help create a culture of personalized medicine for people with epilepsy.

The leader in Sudden Unexpected Death in Epilepsy (SUDEP) research, CURE has awarded 21 SUDEP-related grants, totaling more than $2 million, since 2004. In 2012, the organization pioneered the first-ever Partners Against Mortality in Epilepsy (PAME) meeting and launched the Infantile Spasms (IS) Research Initiative to accelerate the understanding of IS EGIand advance a new, innovative therapy into the clinic. With $2.1 million in grant funding to date, eight teams of investigators are focusing on cutting-edge research for IS, a rare childhood epilepsy syndrome. The project involves investigators at multiple institutions around the country and uniquely promotes a multidisciplinary, team science approach that encourages collaboration between researchers.

CURE boasts an internal scientific team made up of three accomplished epilepsy researchers, committed to helping find a cure. There is a Scientific Advisory Council comprised of five esteemed epilepsy specialists and more than 300 scientist volunteers who lend their expertise in the field to review grant applications. CURE has a Lay Review Council (LRC) made up of volunteers who have a special interest in understanding epilepsy research. Members of the LRC participate in CURE’s grant review process and read research proposals to ensure the stakeholder point of view is critically represented at all stages.

In 2000, CURE co-sponsored the National Institutes of Health (NIH) Conference—the first of its kind to focus on a cure for epilepsy. In addition, CURE was one of the key sponsors involved in shaping the direction and outcome of a newly commissioned report released in March 2012, The Public Health Dimensions of the Epilepsies. The organization was instrumental in the creation of the NIH Epilepsy Research Benchmarks, which were created to help guide the community toward a cure.

CURE has led a dramatic shift in the epilepsy research community from simply treating seizures to enhancing understanding of underlying mechanisms and causes, so that cures and preventative strategies can be found. CURE’s research program is cutting-edge, dynamic and responsive to new scientific opportunities and directions through both investigator-initiated grants and unprecedented scientific programs and initiatives.

Tireless in its efforts and determination, CURE won’t stop
until a CURE is found for epilepsy.